Old Web
English
Sign In
Acemap
>
authorDetail
>
H Gunn
H Gunn
Novartis
Toxicity
Interleukin 6
Medicine
Pharmacokinetics
Pathology
3
Papers
266
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings.
1996
Clinical Cancer Research
Ronald M. Bukowski
T. Olencki
H Gunn
D. McLain
G T Budd
K Sandstrom
Laurie Tuason
Christine Redovan
Patricia Rayman
Raymond R. Tubbs
D. Resta
Paul Elson
James H. Finke
Show All
Source
Cite
Save
Citations (10)
A Phase I Trial of Intravenous Interleukin-6 in Patients with Advanced Cancer
1994
Journal of Immunotherapy
Jeffrey S. Weber
H Gunn
James Chih-Hsin Yang
David R. Parkinson
Suzanne L. Topalian
Douglas J. Schwartzentruber
Stephen E. Ettinghausen
D. Levitt
Steven A. Rosenberg
Show All
Source
Cite
Save
Citations (50)
Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.
1993
Journal of Clinical Oncology
Jeffrey S. Weber
James Chih-Hsin Yang
Suzanne L. Topalian
David R. Parkinson
D S Schwartzentruber
Stephen E. Ettinghausen
H Gunn
Arnold Mixon
H. I. Kim
David J. Cole
Show All
Source
Cite
Save
Citations (206)
1